(Q54035467)

English

An open, randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.

scientific article published in January 1994

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/8281622

An open, randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/8281622

author name string

B Sorbe

1

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/8281622

C Hallén

2

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/8281622

B Frankendal

3

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/8281622

publication date

1 January 1994

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/8281622

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/8281622

33

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/8281622

4

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/8281622

298-302

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/8281622

Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. The Granisetron Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extrapyramidal reactions with high-dose metoclopramide

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I/II study of the 5-HT3 antagonist GR38032F in the anti-emetic prophylaxis of patients receiving high-dose cisplatin chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracil.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and Vomiting

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ondansetron--a new safe and effective antiemetic in patients receiving high-dose melphalan

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Betamethasone-dixyrazine combination versus high-dose metoclopramide as antiemetic treatment in doxorubicin and cisplatin chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiemetic Efficacy of Dexamethasone Therapy in Patients Receiving Cancer Chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The course of nausea and vomiting after high-dose cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ONDANSETRON WITH AND WITHOUT DEXAMETHASONE TO TREAT CHEMOTHERAPY-INDUCED EMESIS

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First results with ICS 205-930 (5-HT3 receptor antagonist) in prevention of chemotherapy-induced emesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8281622

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S002800050056

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/8281622

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/8281622

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54035467&oldid=2085960937"